Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta‐analysis

Author:

Zhang Ziying¹,Chen Peng²,Xie Hui³,Cao Peiguo¹^ORCID

Affiliation:

1. Department of Oncology Third Xiangya Hospital Central South University Changsha China

2. Department of Urology Xiangya Hospital Central South University Changsha China

3. Department of Thoracic and Cardiovascular Surgery Second Xiangya Hospital Central South University Changsha China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

Reference68 articles.

4. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow‐up;Vogel A;Ann Oncol,2018

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献